The first stage of nation-leading product safety standards and an Australia-first information standard for e-micromobility ...

ARENA has committed $30 million in conditional funding to VSPC for a project which seeks to commercialise a new process for ...

Clinical-stage biotechnology company, Vaxxas, has announced it has completed enrollment for its Phase I clinical trial of a ...